A molecular basis for familial hypertrophic cardiomyopathy: An αβ cardiac myosin heavy chain hybrid gene
G Tanigawa(Howard Hughes Medical Institute), Christine E. Seidman(Harvard University), Scott D. Solomon(Brigham and Women's Hospital), Hans-Peter Vosberg(Max Planck Institute for Medical Research), Susan Kass(Howard Hughes Medical Institute), John A. Jarcho, Jonathan G. Seidman(Harvard University)
Cited by 223
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2022|2.6k